Federal Supply Schedule 36F79725D0121
Award Date
6/1/25
Last Date to Order
5/31/30
Federal Agency
Veterans Integrated Service Network 12
Awardee
The Harvard Drug Group, L.L.C.
Ultimate Awardee
Cardinal Health, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) has awarded a Federal Supply Schedule (FSS) contract, contract number 36F79719D0033, to The Harvard Drug Group, L.L.C., a subsidiary of Cardinal Health, Inc. This multiple-award contract is under the Pharmaceuticals and Drugs (FSS-61-IB) schedule and has a ceiling value of $452,567,150.00, with a period of performance through May 31, 2025. The contract is designed to provide the VA, Department of Defense, and other federal healthcare agencies with a wide...
The federal contract IDV award SPE2D019D0002 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to The Harvard Drug Group, L.L.C., a subsidiary of Cardinal Health, Inc. The single-award IDV, with a total ceiling value of $9,173,347.42, is for the manufacture and distribution of a wide range of pharmaceutical and medical supply products. The task orders issued under this IDV include delivery orders for various over-the-counter medications, medical supplies, and prescription...
The federal contract IDV award SPE2D219D0077 was issued by the Department of Defense's Defense Logistics Agency (DLA) to The Harvard Drug Group, L.L.C. as a single-award indefinite delivery contract. The $21,366,302.60 contract, awarded on September 5, 2019, is for the manufacture and distribution of a range of pharmaceutical products and medical supplies, including various generic medications, over-the-counter drugs, and topical creams and ointments. The original competitive solicitation,...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to The Harvard Drug Group, L.L.C. to provide pharmaceutical products and medical supplies to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The $6,509,967.70 contract, effective from September 15, 2021 through September 14, 2025, was issued without a set-aside designation. The contract aims to ensure an uninterrupted...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB for Drugs, Pharmaceuticals, and Hematology Related Products, awarded by the Department of Veterans Affairs (VA) to Heritage Pharmaceuticals Inc., doing business as Avet Pharmaceuticals Inc. The contract has a ceiling value of $25,000 and a period of performance through April 2023. Additionally, Heritage Pharmaceuticals holds a separate $1.5 million FSS Schedule 65 IB contract with the VA that runs...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Nobelpharma America, LLC, a foreign-owned, self-certified small disadvantaged business. The FSS contract, under Federal Supply Class 65 I B, provides for the delivery of pharmaceutical and hematology-related products to VA facilities nationwide, with a ceiling value of $225,000 and a period of performance through May 2028. Additionally, Nobelpharma America, LLC was awarded a...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Alvogen, Inc., a for-profit manufacturer of pharmaceutical and healthcare products. The contract, valued at $32,885,990.00, is for the provision of pharmaceuticals, drugs, and hematology-related products (FSS-61-IB) to the VA and other federal agencies. The contract has an ultimate completion date of September 1, 2025 and was originally awarded on April 15, 2017. It is...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to The Harvard Drug Group, L.L.C. doing business as Major Pharmaceuticals & Rugby Laboratories Division. This 1-year base contract, with four 1-year option periods, is valued at $10,056,938.10 and aims to provide an uninterrupted supply of Lurasidone Hydrochloride (HCL) tablets in various dosages to the VA, Department of Defense, Bureau of Prisons, Indian Health...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB for Drugs, Pharmaceuticals, and Hematology Related Products. The contracting agency is the Department of Veterans Affairs (VA), specifically Veterans Integrated Service Network 12. The prime contractor is Alpha Cognition USA, Inc., a for-profit manufacturer. The contract has a ceiling value of $25,000.00 and a period of performance through September 30, 2025. It is a multiple award IDV, meaning...